Please login to the form below

90TEN named EMEA Healthcare PR Consultancy of the Year at 2020 SABRE awards

90TEN was last night named Healthcare Consultancy of the Year at the 2020 EMEA SABRE Awards.

1 July 2020, London – Global healthcare communications consultancy 90TEN, part of the Envision Pharma Group, was last night named Healthcare Consultancy of the Year at the 2020 EMEA SABRE Awards.

Commenting on the award win, Paul Tanner, Global Head, 90TEN said, “2019 was 90TEN’s most successful year to date, driven by further investment in our team and the continued adoption of the company’s behavioural science-led communications services by clients. It’s terrific to see our ongoing expansion and to receive recognition for this across the EMEA region. This award is a reflection of the dedication of our incredible team and clients, who are passionate about making a difference through life changing work.”

The consultancy was also a finalist for the Best Digital Campaign category for its ‘HIV Garage’ programme for Gilead Sciences.

The SABRE Awards are the world's largest PR awards programme, recognising superior achievement in branding and reputation in North America, EMEA, Asia-Pacific, Latin America, South Asia and Africa. The awards are delivered by PRovoke Media, the authoritative voice of the global public relations industry.

-       ends      -

About 90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and communications. 90TEN provides PR, medical communications, and patient advocacy services that use behavioural science methodologies to maximise brand and health outcomes. 90TEN is one of the leading healthcare communications consultancies in Europe. In 2019, 90TEN was named Communications Consultancy of the Year at the Communiqué Awards; European Agency of the Year at the PR Week Global Awards; Specialist Consultancy of the Year at the PR Week UK Awards; and Support Agency of the Year at the PMEA Awards. 90TEN is part of the Envision Pharma Group – a global provider of evidence-based communication services and industry-leading technology solutions. To find out more, visit

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision®) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 14 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 800 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit

1st July 2020


PDF File: 144.1 KB



Company Details


+44 (0)20 7627 0990

Contact Website

Battersea Studios
80 Silverthorne Road

Latest content on this profile

Award-winning health agency 90TEN launches in the US
Agency veteran Kate Paxton appointed to lead operation, bringing nearly 30 years of global and US biopharma experience.
90TEN promotes Claire Long and Sabrina Gomersall to lead Communications division
Senior leadership team further bolstered by appointment of Rick Evans to the newly created role of Social Strategy Director
90TEN seeks US Head to lead expansion of its PR division in the region
90TEN is seeking an ambitious and driven healthcare communicator to lead the expansion of its award-winning public relations division into the US.
90TEN strengthens senior management team to enhance behavioural science and creative services
90TEN announces the establishment of a new role of Head of Behavioural Sciences along with three promotions within the senior management team and two new hires, enhancing the company’s behavioural science and creative capabilities.
90TEN Chemistry

We are 90TEN